z-logo
open-access-imgOpen Access
Reconstitution of T-cell-mediated immunity in patients after allogeneic stem cell transplantation
Author(s) -
Н. Н. Попова,
В Г Савченко
Publication year - 2020
Publication title -
gematologiâ i transfuziologiâ
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.126
H-Index - 5
eISSN - 2411-3042
pISSN - 0234-5730
DOI - 10.35754/0234-5730-2020-65-1-24-38
Subject(s) - stem cell , immune system , transplantation , immunology , immunity , t cell , hematopoietic stem cell transplantation , haematopoiesis , medicine , cell , biology , microbiology and biotechnology , genetics
Background . The timely reconstitution of the donor-derived immune system is a key factor in the prevention of such post-transplant complications as graft versus host disease, relapse or secondary tumours and various infections. These complications affect the long-term survival of patients after allogeneic stem cell transplantation. Aim — to describe the main stages of T Cell–mediated immune recovery in patients after allogeneic stem cell transplantation. General ndings . T-cell–mediated immunity is responsible for anti-infective and anti-tumour immune response. The early post-transplant period is characterized by the thymus-independent pathway of T-cell recovery largely involving proliferation of mature donor T cells, which were transplanted to the patient together with hematopoietic stem cells. To a lesser extent, this recovery pathway is realized through the expansion of host naïve and memory T cells, which survived after conditioning. Thymus-dependent reconstitution involves generation of de novo naïve T cells and subsequent formation of a pool of memory T-cells providing the main immunological effects — graft versus tumour and graft versus host reactions. A better understanding of the T-cell immune reconstitution process is important for selecting optimized pre-transplant conditioning regimens and patient-specic immunosuppressive therapy approaches, thus reducing the risks of post-transplant complications and improving the long-term survival of patients after allogeneic stem cell transplantation.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here